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Abstract
Background
Since ancient time nature has been used as the main source of herbal medicines. Even
today  many  drugs  derive  or  are  elaborated  from  environmental  ﬂora.  Of  note  natural
products are fundamental sources of new anticancer drugs. Cancer is the second leading
cause of death in the world and the ﬁght against it  still  open and need every possible
resources, including herbal product, which should be scientiﬁcally and deeply studied.
New information
Saxifraga aizoides extract (SAE) has been never tested in preclinical tumor cell models.
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Overview and background
The use of herbal natural products is still the main source of medicines in many developing
nations and is becoming increasingly popular among Western countries, especially over
the  past  decades.  Given  the  extraordinary  interest  about  phytomedicine  and
ethnopharmacology, many researchers all over the world try to deepen and to understand
the  exact  mechanism  by  which  an  herbal  extract  will  interact  with  human  body,  and
particularly with human diseases. In fact many successful uses of plant medicines have
been  derived  from  traditional/geographical  use  of  plant,  whose  eﬀects  have  been
scientiﬁcally proved in recent years. In this context Traditional Chinese Medicine is gaining
popularity  and  therapeutic  eﬃcacy,  as  numerous  researchers  (especially  from  China)
scientiﬁcally investigated its role in human diseases (Leung et al. 2016, Zhang et al. 2010).
The simplest way to use a plant is eating it, but of course this can be very dangerous.
Consequenlty  human skill  developed  diﬀerent  methods  to  beneﬁt  from the  therapeutic
eﬀects of a plant. The ﬁrst method was probably a simple aqueous solution, unfortunately
suitable only for hydrophilic substances. Only later in history mankind discovered the use of
special solutions, which can that can extract both hydrophilic and hydrophobic substance.
Indeed a crude extract, which typically uses alcohol as a solvent, can be considered the
simplest way to obtain a potential therapeutic mixture (Kiefer and Barrett 1999).
Saxifraga is the largest genus in the family Saxifragaceae, containing about 440 species of
holarctic perennial plants, known as saxifrages or rockfoils (Wikipedia 2016). Their name
derives from latin word "saxifraga" that means "stone-breaker" which is traditionally thought
to indicate a medicinal  use for  treatment of  urinary calculi  (kidney stones).  Among the
genus, Saxifraga aizoides is a ﬂowering herb and alpine plant (Fig. 1), that lives in cold and
moist well draining neutral or basic bedrock, sand, or cliﬀ environments (Pignatti 1982). It is
common in North America,  Greenland,  Europe (including the Alps,  Svalbard and Tatra
Mountains) (Pignatti 1982). The ﬂowers (Fig. 2) have with ﬁve sepals and petals (yellow—
green) and the plant grows to 2–10 centimetres spreading by short rhizomes and mats of
small colonies (Wikipedia 2016b). Only few works analyzed the eﬀects of Saxifragaceae
extracts on cancer cell models. Some authors demonstrated anti-cancer eﬀects of diﬀerent
components of Saxifragaceae extracts (Lu et al. 2013, Luo et al. 2015, Kim et al. 2014,
Chen et al. 2008), however up to now no research has tested the eﬃcacy of Saxifraga
aizoides (Fig. 1) extract on any cancer cell lines.
Objectives
The aim of this project is to study the phytochemical proﬁle of the ethanolic crude extract of
Saxifraga aizoides (Fig.  1)  in  preclinical  tumor cell  models.  Moreover  the research will
investigate the eﬀects of the crude extract on cell  viability and vitality and the eventual
alterations of morphologic proﬁle of cell lines. In addition the clonogenic assay will allow to
study the inﬂuence of the crude extract on the capacity of forming cell colonies. All together
these experiments will give a clear and general hypothesis on the eﬃcacy of the extract on
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human ovarian, colon, prostate and breast cancer cell models, in which the crude extract
will be tested. Cell lines to be used: SK-OV-3 (ovarian cancer), Caco2 (colon cancer), PC-3
(prostate cancer), MCF-7 (breast cancer).
Impact
This research project will try to discovery the novel eﬀects of a Saxifraga aizoides crude
extract (SAE). In particular it will explore the anti-proliferative role of SAE in 4 human cell
 
 
Figure 1. 
Saxifraga aizoides is a ﬂowering herb of the genus Saxifraga, which lives in Europe and North
America.
Figure 2. 
Saxifraga aizoides: the characteristic yellow ﬂowers punctuated by orange spots on the petals.
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models (ovarian, colon, prostate and breast cancer) and also in animal models (mice and
rats) to evaluate anti-inﬂammatory and toxicity of SAE.
Implementation
Future perspectives
The research project aims at understanding the potential application of Saxifraga aizoides
extract (SAE) on cancer cell models. In order to achieve this result, a scientiﬁc approach
should be followed:
Materials and methods 
Plant material 
Saxifraga aizoides plant  was collected in  summer  season 2015 at  about  2000 meters
above the  sea level  in  Passo del  Tonale  (TN),  Italy.  Plant  was  identiﬁed according  to
Pignatti  1982. A voucher specimen number was deposited in the herbarium of the OU
Endocrinology,  University  of  Padova,  with  number  011SA.  Plant  was  air-dried  and
powdered. 30g of powder was added to a mixture with ethanol (70%) for 24 h, then ﬁltered.
The solvent was removed by vacuum evaporator. A crude extract of Saxifraga aizoides was
obtained (SAE).
GC/MS analysis of Saxifraga aizoides extract 
The  chemical  analysis  will  be  performed  by  re-solubilizing  the  dry  extract  in  ethanol
followed by gas-chromatography/mass spectrometry (GC/MS) analysis Cavaggioni et al.
2006).
Evalutation of anti-proliferative activity 
Four diﬀerent cell lines will be used: HeLa (ovarian cancer), HCT-116 (Colon cancer), PC-3
(Prostate cancer), MCF-7 (breast cancer) cell lines. Cell lines will be obtained by ATCC or
will  be  a  gift  of  other  research  labs.  Cells  will  be  cultured  in  DMEM/RPMI  medium
supplemented with 10% FBS, 100 U/ml penicillin, 100 ug/ml streptomycin in a humidiﬁed
atmosphere with 5% CO  at 37°C. Cells will be plated on 96-well tissue culture microtiter
plates at a density of 1x10  cells/well and treated with SAE, at diﬀerent concentrations.
MTT cell  viability  (Sigma-Aldrich)  will  be  tested  after  72  h  of  treatment,  as  described
elsewhere. For each drug, we measured the Inhibitory Concentration 50 (IC , deﬁned as
50%  of  the  inhibitory  eﬀect  on  cell  viability).  All  experiments  will  be  performed  in
quadruplicate and repeated three times.
The cytotoxic eﬀects of SAE will be conﬁrmed by the Trypan blue dye exclusion method.
The assay will be performed at 72 h after treatment, using the single IC  dose determined
by MTT assay. At the end of treatment, cells will be collected by trypsinization, centrifuged
and the cell pellet will  be resuspended in 1 ml of PBS. Next, 10 ul of the resulting cell
suspension will be admixed with 10 ul of Trypan blue (0.4% in PBS). The numbers of non-
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stained viable cells (NSt cells) and stained dead cells (St cells) will be counted using a
hemocytometer. Cell viability will be then calculated by the following formula: Viability (%)=
¼ (NSt cells)/(St cells + NSt cells) x 100. Experiments will be performed in triplicated and
repeated three times. The results will be interpreted as the ratio of viable cells after drug
treatments to that of the untreated control.
Cell morphology assessment with Wright’s staining 
Cells will be cultured on coverslips for 48h, incubated overnight in 0.1% FBS, and then
treated with SAE for 72h. After that, cells will be washed in PBS, ﬁxed in methanol for 5 min
and Wright’s stained for 5 min. Cell morphology will be assessed by light microscopy at
x400 magniﬁcation. The experiments will be repeated twice.
Statistical analysis 
Statistical  analysis  will  be  performed  using  GraphPad  Prism  5  software  (GraphPad
Software, Inc., San Diego, CA) and Microsoft Excel software. Cell line data will be analyzed
using  a  two-tailed  paired  Student’s  t-test.  A  p<0.05  will  be  considered  statistically
signiﬁcant. Data will be expressed as mean ± standard error of mean (sem).
Expected results 
We expect to obtain a SAE that will be used to explore its eﬀects on cell cancer models.
We will have a GC/MS proﬁle of SAE. We will test the 4 cancer cell lines for viability after
treatment with SAE, thanks to MTT and trypan blue assays. Furthermore cells morphology
changes will be assessed by light microscopy. Clonogenic assay will be provide a speciﬁc
insight on cell survival after treatment with SAE.
Implementation 
The  study  of  the  Saxifraga  aizoides extract  (SAE)  will  be  implemented  by  the  in  vivo
experiments on animal models (both mice and rats).
Acute toxicity studies 
The project will analyze the acute toxicity of the plant extract, evaluating the lethal dose
(LD50) in mice. The method is described in Lorke (1983). Animals (at least 8 mice) will be
deprived of food over night before testing. SAE will  be administred per os in increasing
doses (10, 100, 1000 mg/kg). Treated animals will be observed for 8 h looking for signs of
toxicity. After 24h, if  no animal will  die, another scaling doses of SAE will  administered
(1500, 3000, 5000 mg/kg). Again animals will be observed for signs of toxicity or mortality.
Anti-inﬂammatory studies 
Anti-inﬂammatory  study will  be performed using wistar  rats.  The method is  derived by
Winter et al. (1963). Aspirin (250 mg/kg) will be a positive control in a group of animals (at
least 6 rats). Another group of animals (at least 6 rats) will be administred with Saxifraga
aizoides extract. The treatments will start 1 hour before carrageenan injection (the drug will
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induce an inﬂammatory reaction in the site of injection). Carrageenan will be prepared as
1% w/v solution in 0.9% w/v NaCl and 0.1 ml will be injected near rat's paw. The paw size
will be measured will digital calliper in the 2 diﬀerent groups and in the control group (no
extract and no aspirin), at 0, 2, 4, 6 h after carrageenan injection.
Ethics 
The request to use animal models will be submitted to Local Ethics Committee only after
successfully completion of in vitro studies. Procedures involving animals and their care will
be in conformity with institutional guidelines that comply with national and international law
and policies  (D.L.  116/92  and  subsequent  implementing  circulars),  and  experimental
protocols will be approved by the Local Ethics Committee of Padua University (CEASA).
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